Perrigo logo

Perrigo

PRGO | NYSE
Chart Builder DCF Calculator
$14.13
+$0.57 (+4.20%)
At close: Sep 21, 2026, 4:00 PM ET
$14.13
$0 (0.00%)
After-hours: Sep 21, 2026, 4:01 PM ET

Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Key Executives

Name Position
Albert Ange Manzone Interim President, Interim CEO & Director
Eduardo Guarita Bezerra Executive Vice President & Chief Financial Officer
Abbie Lennox Executive Vice President & Chief Scientific Officer
Charles Atkinson Executive Vice President, General Counsel & Secretary
David Ball EVP and Chief Brand & Digital Officer
Eric S. Jacobson Vice President of Global Investor Relations
Matthew Winterman Executive Vice President of Product Supply, Operations Strategy & Transformation Officer
Robert Willis Chief Human Resources Officer & Executive Vice President
Roberto Khoury Executive Vice President & Chief Commercial Officer
Sonia Hollies Senior VP & Treasurer

Latest SEC Filings

Date Type Title
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 05, 2026 10-Q Quarterly Report
Aug 05, 2026 8-K Current Report
Jul 29, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 23, 2026 4 Filing
Jul 15, 2026 4 Filing
Jul 15, 2026 4 Filing
Jul 14, 2026 3 Filing
Jul 10, 2026 3 Filing
Jul 10, 2026 4 Filing
View All SEC Filings
Perrigo
Perrigo logo
Country Ireland
IPO Date Dec 16, 1991
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 8,100
CEO Albert A. Manzone

Contact Details

The Sharp Building Dublin, DU D02 TY74 Ireland

Stock Details

Ticker Symbol PRGO
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001585364
CUSIP Number n/a
ISIN Number IE00BGH1M568
SIC Code 2834

© 2026 bestshares.com. All rights reserved.